Groupleader: Thierry BOON
Email: boon
bru.licr.org
contact: LUDWIG INSTITUTE
AVENUE HIPPOCRATE 74
1200 BRUXELLES
Tel: +32 2/764.75.80
Fax: +32 2/764.75.90
LICR Unit Directory (People)
Research interest
The Brussels Branch specializes in cancer immunology and cancer genetics. The notion that the immune system might be enlisted to rid the body of cancer draws on past work at the Branch which revealed that most human tumors bear antigens that can be recognized by cytotoxic T. lymphocytes (CTLs). Some of these antigens are highly tumor-specific, whilst others are expressed on certain normal cells. A number of antigens have been found on many different types of tumors, suggesting that a therapeutic strategy targeting such antigens could be used to treat a wide range of cancers. The Brussels Branch continues the search for tumor antigens, and evaluates their therapeutic potential in vaccine trials of cancer patients.